Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Abbott Laboratories (ABT) had Revenue of $11.16B for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$11.16B
Net Income	$1.08B
Cost of Goods Sold	$4.89B
Gross Profit	$6.27B
Operating Expenses	$9.82B
Operating Income	$1.34B
Non-Operating Income/Expense	$104.00M
Pre-Tax Income	$1.45B
Normalized Pre-Tax Income	$1.45B
Income after Taxes	$1.08B
Income from Continuous Operations	$1.08B
Consolidated Net Income/Loss	$1.08B
Normalized Income after Taxes	$1.08B
EBIT	$1.34B
EBITDA	$2.15B
Weighted-Average Shares Outstanding (Basic)	1.74B
Weighted-Average Shares Outstanding (Diluted)	1.75B
Earnings per Share (EPS) (Basic)	$0.62
Earnings per Share (EPS) (Diluted)	$0.61
Balance Sheet Financials
Current Assets	$25.51B
Property, Plant, and Equipment	$12.38B
Long-Term Assets	$84.92B
Total Assets	$110.43B
Current Liabilities	$18.38B
Long-Term Debt	$29.64B
Long-Term Liabilities	$39.35B
Total Liabilities	$57.73B
Common Equity	$52.70B
Tangible Shareholders Equity	$-395.00M
Shareholders Equity	$52.70B
Common Shares Outstanding	1.74B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.31B
Cash Flow from Investing Activities	$-20.32B
Cash Flow from Financial Activities	$17.31B
Beginning Cash	$8.52B
End Cash	$6.80B
Increase/Decrease in Cash	$-1.72B
Stock-Based Compensation	$317.00M
Common Stock Dividends Paid	$-1.10B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.39
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.65
Gross Margin	56.20%
Operating Margin	12.05%
EBIT Margin	12.05%
EBITDA Margin	--
Pre-Tax Profit Margin	12.98%
Profit Margin	9.65%
Free Cash Flow	$916.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.70
Receiveable Turnover	1.36
Days Sales in Receivables	66.19
Return on Equity	2.04%
Return on Tangible Equity	-272.66%
Return on Assets	0.98%
Return on Investments	1.31%
Book Value Per Share	$30.26
Free Cash Flow per Share	$0.52
Operating Cash Flow per Share	$0.75

Data from Zacks Investment Research, Inc.